Benchmark Electronics, Inc. (NYSE:BHE), a global provider of engineering, design, and manufacturing services, and consumer genetic testing pioneers DnaNudge, today announced a key manufacturing partnership to deliver volume production of DnaNudge's rapid, lab-free reverse transcription polymerase chain reaction (RT-PCR) COVID-19 testing system. DnaNudge's ground-breaking consumer DNA testing innovation, which requires no lab and delivers results in just over an hour, has been re-engineered as a testing system to accurately detect COVID-19. In August, the U.K. government announced an order for 5.8 million CovidNudge testing kits to be rolled out in NHS hospitals and out-of-hospital locations across the U.K. starting September 2020, following successful validation.
Benchmark's Herman Bartelink had the opportunity to showcase the new DnaNudge CovidNudge manufacturing line with Dutch television news segment EénVandaag.
To view the original story in Dutch, visit NPO's website here.
To learn more about DnaNudge and their rapid testing system, visit their website.